跳至主要内容
临床试验/IRCT2016092813739N5
IRCT2016092813739N5已完成1 期

Comparing the effects of a-L-Guluronic acid with conventional Non-steroidal anti-inflammatory drugs on disease activity and inflammatory markers in patients with Rheumatoid Arthritis

Vice-Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 60 years(—)
性别
All

入选标准

  • Inclusion Criteria: 25-60 years old patients, Diagnosed with RA according to American College of Rheumatology Diagnostic Criteria after the initial visit by a specialist in rheumatology and parameters ESR, RF, CRP and Anti-CCP elected, Each patient must sign written informed consent.

排除标准

  • History of fever and Infectious diseases, Positive pregnancy test or Lactation, Other collagen- vascular diseases, Other auto-immune diseases, Malignancies, Patients have enrolled another clinical trial study within last 4 weeks, Other concomitant diseases (Hepatic, renal, haematological, gastrointestinal, endocrine, cardiovascular, pulmonary, neurological or cerebral disease).

研究者

发起方
Vice-Chancellor for Research, Tehran University of Medical Sciences

相似试验

已完成
1 期
The therapeutic effects of a-L-Guluronic acid in patients with ankylosing spondylitisAnkylosing spondylitis.Ankylosing spondylitis
IRCT2016091813739N4Vice-Chancellor for Research, Tehran University of Medical Sciences25
已完成
1 期
The therapeutic effect of Glucuronic acid in breast cancer patientsCondition 1: Breast Cancer. Condition 2: Breast Cancer. Condition 3: Breast Cancer. Condition 4: Breast Cancer. Condition 5: Breast Cancer. Condition 6: Breast Cancer. Condition 7: Breast Cancer. Condition 8: Breast Cancer.Malignant neoplasm: overlapping lesion of breastMalignant neoplasm: upper-inner quadrant of breastMalignant neoplasm: lower-inner quadrant of breastMalignant neoplasm: upper-outer quadrant of breastMalignant neoplasm: lower-outer quadrant of breastMalignant neoplasm: axillary tail of breastMalignant neoplasm: breast, unspecifiedMalignant neoplasm: nipple and areola
IRCT2017061113739N9Vice-Chancellor for Research, Tehran University of Medical Sciences36
尚未招募
3 期
Evaluation of efficacy and safety of Glurunic acid (G2013) in patients with COVID-19COVID-19.Covid-19U07.1
IRCT20080901001165N64Ministry of Defense, Department of Health180
已完成
不适用
Effects of oral administration of lauric acid on gut hormone release and appetite perceptions in healthy peopleType 2 diabetesHealthy Human Gastrointestinal PhysiologyDiet and Nutrition - ObesityOral and Gastrointestinal - Normal oral and gastrointestinal development and functionMetabolic and Endocrine - DiabetesObesity
ACTRN12619000075189Prof. Christine Feinle-Bisset10
已完成
不适用
Treatment of Acne scars
CTRI/2018/02/012050Andrea Rosario30